Cargando…
A phase II study of neoadjuvant capecitabine, oxaliplatin, and irinotecan (XELOXIRI) in patients with locally advanced rectal cancer
PURPOSE: Addition of perioperative multi‐agent chemotherapy to the treatment strategy for locally advanced rectal cancer (LARC) may be a promising option. We conducted a phase II study to evaluate the safety and efficacy of capecitabine combined with oxaliplatin and irinotecan (XELOXIRI) as triplet...
Autores principales: | Matsuda, Chu, Kudo, Toshihiro, Morimoto, Yoshihiro, Kagawa, Yoshinori, Tei, Mitsuyoshi, Ide, Yoshihito, Miyoshi, Norikatsu, Takahashi, Hidekazu, Uemura, Mamoru, Takemasa, Ichiro, Satoh, Taroh, Mizushima, Tsunekazu, Murata, Kohei, Doki, Yuichiro, Eguchi, Hidetoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831889/ https://www.ncbi.nlm.nih.gov/pubmed/36643362 http://dx.doi.org/10.1002/ags3.12600 |
Ejemplares similares
-
Safety and efficacy of irinotecan, oxaliplatin, and capecitabine (XELOXIRI) regimen with or without targeted drugs in patients with metastatic colorectal cancer: a retrospective cohort study
por: Liu, Xiu, et al.
Publicado: (2022) -
Comprehensive profiling of novel epithelial–mesenchymal transition mediators and their clinical significance in colorectal cancer
por: Ishikawa, Satoshi, et al.
Publicado: (2021) -
Surgical resection for pelvic retroperitoneal Castleman's disease: A case report and review literature
por: Kitakaze, Masatoshi, et al.
Publicado: (2021) -
Specific activation of glycolytic enzyme enolase 2 in BRAF V600E‐mutated colorectal cancer
por: Yukimoto, Ryohei, et al.
Publicado: (2021) -
Long Distance Between the Superior Mesenteric Artery Root and Bottom of the External Anal Sphincter Is a Risk Factor for Stoma Outlet Obstruction After Total Proctocolectomy and Ileal‐Pouch Anal Anastomosis for Ulcerative Colitis
por: Mori, Ryota, et al.
Publicado: (2021)